Detalles de la búsqueda
1.
Nasopharyngeal Carriage of Pneumococcus in Children in England up to 10 Years After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Persistence of Serotypes 3 and 19A and Emergence of 7C.
J Infect Dis
; 227(5): 610-621, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36130327
2.
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Clin Infect Dis
; 76(2): 201-209, 2023 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36196614
3.
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Lancet
; 399(10319): 36-49, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34883053
4.
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Clin Exp Immunol
; 211(3): 280-287, 2023 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729167
5.
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Lancet
; 398(10304): 981-990, 2021 09 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480858
6.
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
Lancet
; 397(10282): 1351-1362, 2021 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33798499
7.
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Lancet
; 398(10303): 856-869, 2021 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34370971
8.
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Lancet
; 396(10267): 1979-1993, 2021 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33220855
9.
Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine.
Mol Syst Biol
; 16(11): e9888, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33210468
10.
Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
JAMA
; 315(15): 1610-23, 2016 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27092831
11.
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
Pediatr Infect Dis J
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717982
12.
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants.
Vaccine
; 41(19): 3019-3023, 2023 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37045683
13.
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
J Infect
; 87(3): 230-241, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37331429
14.
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
J Infect
; 86(6): 574-583, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37028454
15.
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.
iScience
; 26(12): 108500, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089581
16.
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
EBioMedicine
; 81: 104128, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779491
17.
Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019-2021.
Arch Dis Child
; 2022 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858775
18.
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.
JCI Insight
; 7(7)2022 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35192543
19.
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
Lancet Respir Med
; 10(11): 1049-1060, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690076
20.
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.
Clin Microbiol Infect
; 28(12): 1649.e1-1649.e8, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35840033